Large coronary thrombus: A safe and effective approach using percutaneous coronary intervention after vigorous

Danny Dvir1, Hironori Kitabata, Ron Waksman

  • 1Interventional Cardiology, Washington Hospital Center, Washington, DC 20010, USA.

Insights

High thrombotic burden after coronary intervention can cause poor blood flow. An alternative approach using aggressive antithrombotic therapy before intervention successfully treated patients with large thrombi.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Thrombosis Research

Background:

  • High thrombotic burden post-percutaneous coronary intervention is linked to microvascular obstruction and the no-reflow phenomenon.
  • Conventional thrombectomy may worsen outcomes by dislodging thrombi and reducing myocardial perfusion.

Purpose of the Study:

  • To present an alternative strategy for managing coronary vessels with a significant thrombotic burden.
  • To evaluate the efficacy of a delayed intervention approach following intensive pharmacological therapy.

Main Methods:

  • Treatment of a coronary vessel with a large thrombotic burden.
  • Initial vigorous pharmacological antithrombotic and antiplatelet therapy.
  • Subsequent coronary intervention performed several days after initial therapy.

Main Results:

  • Successful treatment of the coronary vessel with a large thrombotic burden.
  • Avoidance of complications associated with immediate mechanical thrombectomy.
  • Improved myocardial perfusion achieved through the staged approach.

Conclusions:

  • A staged approach involving initial intensive pharmacological therapy followed by delayed coronary intervention is a viable alternative for patients with high thrombotic burden.
  • This strategy may mitigate risks associated with mechanical thrombectomy and improve outcomes in complex coronary interventions.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...